Loading

Leverna Therapeutics

June 06, 2024
Session
Company Description: Leverna is a Boston-based RNA therapeutics company. We focus on drugging RNA regulation in the CNS to flexibly control targets by up-regulation, down-regulation, functional activation, or inhibition. Our proprietary LEVERAGER platform decodes RNA regulation information and enables development of smart ASOs to re-direct the fate of RNA, with potentially superior safety. We have multiple programs in CNS and CNS-related diseases currently in preclinical stage. All programs exploit novel, druggable RNA processing mechanisms.

Leverna Therapeutics
View all SUS 2024

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS